Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy variable (II)-22-1 (IGHVII-22-1)
- Target
- IGHVII-22-1
- Molecular classification
- Pseudogene, Immunoglobulin heavy chain variable gene segment, Antibody variable region gene family, Other
01
Overview
Immunoglobulin heavy variable (II)-22-1 (IGHVII-22-1) is a member of the immunoglobulin heavy chain variable region gene family. This locus appears in genomic databases as a poorly expressed or pseudogene segment, with insufficient evidence for functional mRNA or translation into a functional protein product. Unlike canonical immunoglobulin variable regions, which encode antibody diversity for antigen recognition, IGHVII-22-1 is highly likely to be non-functional, not involved in antigen binding, and not a molecular target for drugs, biomarkers, or therapies. Its designation is sometimes confused with other immunoglobulin variable genes, but there are no references describing it as a receptor, enzyme, or bona fide therapeutic target[1][2][3]. For scientific and therapeutic purposes, IGHVII-22-1 should not be regarded as a drug target, receptor, or biomarker. Its inclusion in a target list is likely erroneous or irrelevant to drug discovery and clinical research[1][2].
- Other names
- IGHV(II)-22-14-22.1PIGHVII221IGHVII-22-1IGHVII-221
02
Mechanism of action
None reported
03
Biological functions
None established in the literature for this specific geneGeneral family: possible involvement (if expressed) in variable antigen recognition of antibodies[2][3]For this entry, likely none
04
Disease associations
None established; not linked to disease mechanisms or therapeutic interventionsGeneral family can participate in immune response, but not for this specific pseudogene
05
Safety considerations
None known; as a non-functional or poorly expressed pseudogene, it should not present safety/therapeutic concerns
06
Interacting drugs
None reported
07
Biomarkers
None reported
Beyond the preview
Go deeper on Immunoglobulin heavy variable (II)-22-1 (IGHVII-22-1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Immunoglobulin heavy variable (II)-22-1 (IGHVII-22-1).